Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
McCulloch D, Brown C, Iland H. Onco Targets Ther. 2017;10:1585–1601.
On page 1594, Table 3 contained several errors.
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Other article by this author:
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
McCulloch D, Brown C, Iland H
Published Date: 14 March 2017